Method for treating ophthalmic disorders with IGFBP
First Claim
Patent Images
1. A method for treating an individual who has undergone or is about to undergo or is undergoing ophthalmic surgery to promote healing without vision limiting scarring, said method comprising administering to said individual insulin-like growth factor binding protein-3 (IGFBP-3), said IGFBP-3 being administered in an amount sufficient to promote healing without vision limiting scaring, wherein said amount is administered by local or topical administration at 3 μ
- g to 3 mg per eye.
1 Assignment
0 Petitions
Accused Products
Abstract
This is a method for treating ophthalmic disorders associated with an excess of IGF-I or IGF-II. The method comprises administering individuals with an IGF excess insulin-like growth factor binding protein (IGFBP). The preferred form is IGFBP-3.
26 Citations
14 Claims
-
1. A method for treating an individual who has undergone or is about to undergo or is undergoing ophthalmic surgery to promote healing without vision limiting scarring, said method comprising administering to said individual insulin-like growth factor binding protein-3 (IGFBP-3), said IGFBP-3 being administered in an amount sufficient to promote healing without vision limiting scaring, wherein said amount is administered by local or topical administration at 3 μ
- g to 3 mg per eye.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
11. A method for treating an individual who has undergone, is about to undergo, or is undergoing corneal transplant surgery, comprising locally or topically administering 3 μ
- g to 3 mg insulin-like growth factor binding protein-3(IGFBP-3) to said individual.
- View Dependent Claims (12, 13, 14)
Specification